Abstract
Hexachlorophene (HCP) or 2.2’-methylene bis (3, 4, 6-trichlorphenol) formerly used as germicide, given in the diet of animals, or absorbed through the skin of newborn animals or humans, produces severe oedema in the white matter of the central nervous system (Kimbrough 1971 and 1973; Lampert et al 1973; Mullick 1973; Towfighi 1980). In accordance with Klatzo’s definition (Klatzo 1967) the hexachlorophene-induced brain oedema is characterized as cytotoxic oedema. We intend to use this brain oedema as a model for testing cerebroprotective substances. Therefore rats, put on a diet containing high concentrations of HCP, were examined and the recovery of the rats, after cessation of HCP-exposure, was observed with respect to the water, sodium and potassium content of the brain, the histology of the cerebellum and the motor behaviour. With special respect to the question of suitability as a model for testing of cerebroprotective substances, the oedema reducing effect of substances used to manage brain oedema or of potential therapeutic value was tested.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baethmann A, Oettlinger W, Moritake K, Chaussy L, Jesch F (1982) Metabolic effects of corticosteroids in central nervous tissue. In: Hartmann A, Brock M (eds) Treatment of cerebral oedema, Springer, Berlin Heidelberg New York, pp 24–30
Kimbrough RD (1973) Review of recent evidence of toxic effects of hexachlorophene. Pediatrics 51:391–397
Kimbrough RD, Gaines TB (1971) Hexachlorophene effects on the rat brain: study of high doses by light and electron microscopy. Arch Environmental Health 23: 114–120
Klatzo I (1967) Presidential adress: neuropathological aspects of brain oedema. J Neuropath exp Neurol 26:1–14
Klein HJ, Schmidt K (1982) Hyperosmolar solutions and diuretics in the treatment of brain oedema. In: Hartmann A, Brock M (eds) Treatment of cerebral oedema, Springer, Berlin Heidelberg New York, pp 81–99
Lampert PW, O’Brien J, Garrett R (1973) Hexachlorophene encephalopathy. Acta Neuropathol 23: 326–335
Mullick FG (1973) Hexachlorophene toxicity: Human experience at the AFIP. Pediatrics 51:395–401
Schmidt J (1982) Zur Phannakologie der Nootropika. In: Oehme P, Lowe H, Gores E (eds) Beitrage zur Wirkstofforschung, vol 17, Akademie-Industrie-Komplex Arzneimittelforschung, Berlin, pp 1–175
Towfighi I (1980) Hexachlorophene. In: Spencer PS, Schaumburg HH (eds) Experimental and Clinical Neurotoxicology, Williams and Wilkins, Baltimore London, pp 440–455
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Andreas, K. (1991). Cytotoxic Brain Oedema as a Model in the Examination of Cerebroprotective Substances. In: Chambers, P.L., Chambers, C.M., Wiezorek, W.D., Golbs, S. (eds) Recent Developments in Toxicology: Trends, Methods and Problems. Archives of Toxicology, vol 14. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74936-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-74936-0_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-51422-0
Online ISBN: 978-3-642-74936-0
eBook Packages: Springer Book Archive